Marco Cosentino Lagomarsino

Dr. Marco Cosentino Lagomarsino obtained a PhD in Physics at the University of Leiden, and he did postdoctoral work at the Curie Institute. Since 2008 he joined IFOM as a Principal Investigator, with a joint appointment as Associate Professor at the University of Milan (Theory and Complex Systems group, Department of Physics). Dr. Lagomarsino leads a theoretical group applying tools and concepts from statistical and soft condensed-matter physics to fundamental questions in biology, such as cell functioning and genome organization. The group is characterized by (i) a quantitative approach, (ii) interdisciplinary work in direct contact with experimentalists, and (iii) a full integration of data analysis and theoretical modeling.

Lab Information

Istituto FIRC di Oncologia Molecolare (IFOM)

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Quantitative Single-cell Physiology 0 Chromosome folding and dynamics 0 Role of molecular crowding in chromosome organization and cell physiology 0 Bioinformatics 0 The Evolutionary Dynamics of Major Genome Rearrangements 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Tovo A, Menzel P, Krogh A, Cosentino Lagomarsino M, Suweis S. Taxonomic classification method for metagenomics based on core protein families with Core-Kaiju [published online ahead of print, 2020 Jul 7]. Nucleic Acids Res. 2020;gkaa568. doi:10.1093/nar/gkaa568

  2. Nastały P, Purushothaman D, Marchesi S, et al. Role of the nuclear membrane protein Emerin in front-rear polarity of the nucleus. Nat Commun. 2020;11(1):2122. Published 2020 May 1. doi:10.1038/s41467-020-15910-9

  3. Russo M, Crisafulli G, Sogari A, et al. Adaptive mutability of colorectal cancers in response to targeted therapies. Science. 2019;366(6472):1473-1480. doi:10.1126/science.aav4474

  4. Corno A, Chiroli E, Gross F, et al. Cellular response upon proliferation in the presence of an active mitotic checkpoint. Life Sci Alliance. 2019;2(3):e201900380. Published 2019 May 8. doi:10.26508/lsa.201900380

  5. Micali G, Grilli J, Osella M, Cosentino Lagomarsino M. Concurrent processes set E. coli cell division. Sci Adv. 2018;4(11):eaau3324. Published 2018 Nov 7. doi:10.1126/sciadv.aau3324


This guy hasn’t plasmids anything yet.

Hot plasmids


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud